Streetbeat News

Analyst Ratings

ABBV

OGN

PINC

Three health care stocks with over 4% dividend yields have been highlighted by Wall Street's most accurate analysts. Organon & Co. (OGN) has a dividend yield of 9.13% but posted weaker-than-expected Q3 results. AbbVie Inc. (ABBV) has a dividend yield of 4.37% and reported better-than-expected Q3 earnings, raising its profit outlook. Premier, Inc. (PINC) has a dividend yield of 4.24% and posted stronger-than-expected Q1 earnings.

Portfolio Pulse from Lisa Levin

November 09, 2023 | 12:36 pm

SPH

Suburban Propane Partners (NYSE:SPH) reported Q4 losses of $(0.33) per share, beating the analyst consensus estimate of $(0.45) by 26.67%. However, the company's quarterly sales of $226.59 million missed the analyst consensus estimate of $233.00 million by 2.75%. This represents a 4.65% decrease over sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:35 pm

NVAX

Novavax reported Q3 earnings per share of $(1.26), beating the analyst consensus estimate of $(1.83) by 31.15%. This is a 41.4% increase over losses from the same period last year. The company also reported quarterly sales of $186.99 million, beating the analyst consensus estimate of $158.54 million by 17.94%. However, this is a 74.55% decrease over sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:35 pm

CSGS

Wells Fargo has initiated coverage on CSG Systems Intl (NASDAQ:CSGS) with an Equal-Weight rating and a price target of $49.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:34 pm

RANI

HC Wainwright & Co. analyst Mitchell Kapoor maintains a 'Buy' rating on Rani Therapeutics Hldgs (NASDAQ:RANI) but lowers the price target from $20 to $16.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:34 pm

KELYA

Kelly Services reported Q3 adjusted earnings of $0.50 per share, beating the analyst consensus estimate of $0.26 by 92.31%. However, the company's quarterly sales of $1.12 billion missed the analyst consensus estimate of $1.17 billion by 4.44%.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:33 pm

IKNA

Ikena Oncology reported Q3 losses of $(0.40) per share, beating the analyst consensus estimate of $(0.43) by 6.98%. However, the company's quarterly sales of $1.19 million missed the analyst consensus estimate of $2.55 million by 53.53%. This represents a 16.67% increase in losses and a 81.49% decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:32 pm

MTSI

MACOM Technology Solns (NASDAQ:MTSI) reported Q4 earnings of $0.56 per share, beating the analyst consensus estimate of $0.55 by 1.82%. However, this is a 27.27% decrease from the same period last year. The company also reported quarterly sales of $150.38 million, beating the estimate of $150.16 million by 0.14%, but this is a 15.59% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:32 pm

SKYT

Needham analyst Rajvindra Gill maintains a 'Buy' rating on SkyWater Technology (NASDAQ:SKYT) but has lowered the price target from $20 to $13.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:32 pm

CYTK

Goldman Sachs analyst Paul Choi has initiated coverage on Cytokinetics (NASDAQ:CYTK) with a Buy rating and a price target of $50.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:31 pm